Drucker Wealth 3.0 LLC Has $325,000 Stock Holdings in Veeva Systems Inc. $VEEV

Drucker Wealth 3.0 LLC lessened its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 27.9% during the 2nd quarter, HoldingsChannel reports. The fund owned 1,142 shares of the technology company’s stock after selling 443 shares during the quarter. Drucker Wealth 3.0 LLC’s holdings in Veeva Systems were worth $325,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. TFB Advisors LLC increased its holdings in Veeva Systems by 1.2% in the first quarter. TFB Advisors LLC now owns 3,586 shares of the technology company’s stock valued at $831,000 after purchasing an additional 44 shares during the last quarter. Triangle Securities Wealth Management increased its holdings in Veeva Systems by 0.8% in the second quarter. Triangle Securities Wealth Management now owns 5,782 shares of the technology company’s stock valued at $1,665,000 after purchasing an additional 45 shares during the last quarter. Marks Group Wealth Management Inc increased its holdings in Veeva Systems by 3.3% in the first quarter. Marks Group Wealth Management Inc now owns 1,427 shares of the technology company’s stock valued at $331,000 after purchasing an additional 46 shares during the last quarter. Harbour Investments Inc. increased its holdings in Veeva Systems by 7.6% in the first quarter. Harbour Investments Inc. now owns 789 shares of the technology company’s stock valued at $183,000 after purchasing an additional 56 shares during the last quarter. Finally, Parallel Advisors LLC increased its holdings in Veeva Systems by 4.7% in the second quarter. Parallel Advisors LLC now owns 1,236 shares of the technology company’s stock valued at $356,000 after purchasing an additional 56 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.

Insider Activity at Veeva Systems

In related news, SVP Jonathan Faddis sold 14,595 shares of the stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.00, for a total transaction of $4,378,500.00. Following the completion of the transaction, the senior vice president directly owned 8,588 shares of the company’s stock, valued at approximately $2,576,400. This represents a 62.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total value of $1,005,134.00. Following the transaction, the insider directly owned 23,773 shares of the company’s stock, valued at $7,132,850.92. This trade represents a 12.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 24,665 shares of company stock valued at $7,438,000. Insiders own 10.30% of the company’s stock.

Veeva Systems Stock Performance

NYSE:VEEV opened at $287.04 on Friday. The company has a market cap of $47.05 billion, a PE ratio of 58.94, a PEG ratio of 2.22 and a beta of 0.98. Veeva Systems Inc. has a 52-week low of $201.54 and a 52-week high of $310.50. The stock has a 50-day simple moving average of $282.91 and a 200 day simple moving average of $265.06.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The firm had revenue of $789.08 million for the quarter, compared to the consensus estimate of $768.49 million. During the same quarter in the previous year, the business posted $1.62 earnings per share. The firm’s quarterly revenue was up 16.7% compared to the same quarter last year. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, research analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Analysts Set New Price Targets

VEEV has been the subject of a number of recent analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of Veeva Systems in a report on Wednesday. TD Cowen upgraded Veeva Systems from a “hold” rating to a “buy” rating and increased their price target for the stock from $297.00 to $380.00 in a report on Tuesday, October 7th. Stifel Nicolaus increased their price target on Veeva Systems from $295.00 to $320.00 and gave the stock a “buy” rating in a report on Thursday, August 28th. BTIG Research increased their price target on Veeva Systems from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Thursday, August 28th. Finally, JPMorgan Chase & Co. upgraded Veeva Systems from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $290.00 to $330.00 in a report on Monday, September 8th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $307.58.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.